Scientists track 7 patients for 5 years after groundbreaking gene therapy

NCT ID NCT06614569

Summary

This study monitors 7 patients for five years after they received an experimental gene therapy for Tay-Sachs or Sandhoff disease. The goal is to check for any long-term safety issues, like cancer or immune system problems, that might develop after treatment. Researchers will also track how the treatment affects the patients' brain function and development over time.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SANDHOFF DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • UMass Chan Medical School

    Worcester, Massachusetts, 01655, United States

Conditions

Explore the condition pages connected to this study.